Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses

Methods

Volumn 49, Issue 4, 2009, Pages 301-308

  Campo, Judith del ^a   Zayas, Caridad ^a   Romeu, Belkis ^a   Acevedo, Reinaldo ^a   González, Elizabeth ^a   Bracho, Gustavo ^a   Cuello, Maribel ^a   Cabrera, Osmir ^a   Balboa, Julio ^a   Lastre, Miriam ^a  

^a FINLAY INSTITUTE   (Cuba)

Author keywords

Adjuvant; Cochleate; Mucosal immunization; Proteoliposome

Indexed keywords

ADJUVANT; ADJUVANT FINLAY COCHLEATE 1; ADJUVANT FINLAY PROTEOLIPOSOME 1; ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; OVALBUMIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG POTENCY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MUCOSAL IMMUNITY; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEOLIPOSOME; SALIVA; SERUM; TH1 CELL; VAGINA SECRETION;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, INTRAVAGINAL; ANIMALS; CELLS, CULTURED; DEOXYCHOLIC ACID; EDETIC ACID; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; NEISSERIA MENINGITIDIS, SEROGROUP B; PROTEOLIPIDS;

MUS; NEISSERIA MENINGITIDIS SEROGROUP B;

EID: 70350712778     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2009.03.025     Document Type: Article

References (40)

1. He Q., Mitchell A., Morcol T., and Bell S.J.D. Clin. Diag. Lab. Immunol. 9 5 (2002) 1021-1024
2. Neutra M.R., and Kozlowski P.A. Nat. Rev. Immunol. 6 (2006) 148-158
3. Mestecky J., Russell M.W., and Elson C.O. The Journal of Immunology: BRIEF REVIEW (2007) 5633-5638
4. Johansen F.E., Baekkevold E.S., Carlsen H.S., Farstad I.N., Soler D., and Brandtzaeg P. Blood. 106 2 (2005) 503-600
5. V. Alcon, M. Baca-Estrada, M. Vega-Lopez, P. Willson, L. A. Babiuk, P. Kumar, R. Hecker, M. Foldvari. AAPS Journal 7(3) (2005) Article 57 (http://www.aapsj.org).
6. Holmgren J., Czerkinsky C., Eriksson K., and Harandi A. Vaccine 21 Suppl 2 (2003) 89-95
7. McGhee J.R., and Kiyono H. Mucosal immunology. In: Paul W.E. (Ed). Fundamental Immunology 909 (1998), Academic Press, San Diego
8. Kuper C.F., Koornstra P.J., Hameleers D.M.H., Biewenga J., Spit B.J., Duijvestijn A.M., van Breda Vriesman P.J., and Sminia T. Immunol. Today 12 (1992) 219
9. Brandtzaeg P. Immunologist 3 89 (1995) 288-311
10. McGhee J., and Kiyono H. Infect. Agents Dis. 2 55 (1993)
11. Langermann S., Palazynski S., Sadziene A., Stover C.K., and Koenig S. Nature 372 (1994) 552
12. Tamura S., Ito Y., Asanuma H., Hirabayashi Y., Suzuki Y., Nagamine T., Aizawa C., and Kurata T. J. Immunol. 149 (1992) 981
13. Mayer L. J. Pediatr. Gastroenterol. Nutr. 30 Suppl (2000) S4-S12
14. C. Campa, V.G. Sierra, M.M. Gutiérrez, et al. Method of producing Neisseria meningitidis B vaccine, and vaccine produced by method. United States Patent 1997, Patent number 5,597 572.
15. Pérez O., Lastre M., Lapinet J., Bracho G., Diaz M., Zayas C., and Taboada C. Infect. Immun. 69 (2001) 4502-4508
16. Pérez O., Lastre M., Cabrera O., del Campo J., Bracho G., Cuello M., Balboa J., Acevedo R., Zayas C., Gil D., Mora N., González D., Pérez R., González E., Barbera R., Fajardo M.E., Sierra G., Solís R.L., and Campa C. Scand. J. Immunol. 66 (2007) 271-277
17. Pérez O., Bracho G., Lastre M., del Campo J., Gil D., Zayas C., Acevedo R., González D., López J.A., Tabeada C., and Solis R.L. Immunol. Cell Biol. 82 (2004) 603-610
18. Rodríguez T., Pérez O., Menager N., Ugrinovic S., Bracho G., and Mastroeni P. Vaccine 26 (2005) 1312-1321
19. O. Pérez, G. Bracho, M. Lastre, N. Mora, J. del Campo, D. Gil, C. Zayas, C. Taboada, R.L. Solís. Método de obtención de estructuras cocleares, Composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios. Patent application Cu 2002-0292.
20. Rodríguez T., Lastre M., Cedré B., del Campo J., Bracho G., Zayas C., Taboada C., Díaz M., Sierra G., and Pérez O. Clin. Diag. Lab. Immunol. 9 1 (2002) 109-115
21. Rodríguez T., Lastre M., Cedré B., Fajardo E.M., del Campo J., Delgado I., Sierra V.G., and Pérez O. Neisseria meningitidis Biologicals. 31 (2003) 209-212
22. Sanchez J.L., Trofa A.F., Taylor D.N., Kuschner R.A., DeFraites R.F., Craig S.C., Rao M.R., Clemens J.D., Svennerholm A.M., Sadoff J.C., et al. J. Infect. Dis. 167 6 (1993) 1446-1449
23. Takeda K., Kaisho T., and Akira S. Annu. Rev. Immunol. 21 (2003) 335-376
24. Singh M., and O'Hagan D. Nat. Biotechnol 17 (1999) 1075-1081
25. Holmgrem J., and Czerkinsky C. Nat. Med. 11 4 Suppl. (2005) 45-52
26. Tengvall S., Josefsson A., Holmgren J., and Harandi A.M. J. Reprod. Immunol. 68 (2005) 53-69
27. Tengvall S., Lundqvist A., Eisenberg R.J., Cohen G.H., and Harandi A.M. J. Virol. (2006) 5283-5291
28. Ronco J., and Guy B. Adjuvants for mucosal vaccines. In: Fuller R., and Perdigon G. (Eds). Probiotics 3: immunomodulation by the gut microflora and probiotics (2000), Kluwer Academic Publishers, Dordrecht, The Netherlands 28-69
29. Bruno G. Clin. Diag. Lab. Immunol. 9 4 (2002) 753-762
30. Elson C.O., and Dertzbaugh M.T. Mucosal adjuvants. In: Ogra P.L., Mestecky J., Lamm M.E., Strober W., McGhee J.R., and Bienenstock J. (Eds). Handbook of mucosal immunology (1994), Academic Press Inc., San Diego, Calif 391-401
31. Ryan E.J., Daly L.M., and Mills K.H.G. Trends Biotechnol 19 (2001) 293-304
32. Baudner B.C., Balland O., Giuliani M.M., Von Hoegen P., Rappuoli R., Betbeder D., and Del Giudice G. Infect. Immun. 70 9 (2002) 4785-4790
33. Haneberg B., Dalseg R., Wedege E., Høiby E.A., Haugen I.L., Oftung F., Andersen S.R., Naess L.M., Aase A., Michaelsen T.E., and Holst J. Infect. Immun. 66 (1998) 1334-1341
34. Lamm M.E. Annu. Rev. Microbiol. 51 (1997) 311-340
35. Espuelas S., Irache J.M., and Gamazo C. Inmunología 24 2 (2005) 208-223
36. Matsunaga Y., Wakatsuki Y., Tabata Y., Kawasaki H., Usui T., Yoshida M., et al. Vaccine 19 4 (2000) 579-588
37. L. David, Mucosal Adjuvants, St. George's Vaccine Institute, UK. www.who.int/vaccine_research/about/gvrf/Lewis.pdf. December 2008.
38. Harandi A.M., Eriksson K., and Holmgren J. J. Virol. 77 (2003) 953-962
39. Price G.A., Russell M.W., and Cornelissen C.N. Infect. Immun. 73 7 (2005) 3945-3953
40. Kozlowski P.A., Williams S.B., Lynch R.M., Flanigan T.P., Patterson R.R., Cu-Uvin S., and Neutra M.R. J. Immunol. 169 (2002) 566-574